Drug profile · INN
desoxycorticosterone acetate
PERCORTEN
desoxycorticosterone acetate (PERCORTEN) is a mineralocorticoid receptor agonist. Route of administration: implantation. Current US regulatory status: approved.
Drug details — desoxycorticosterone acetate
- US status
- approved
- Class
- —
- Route
- IMPLANTATION
- Patents
- 1
- Programs
- 19
- Data quality
- 0.84
Quick answer
desoxycorticosterone acetate (PERCORTEN) is a mineralocorticoid receptor agonist. Route of administration: implantation. Current US regulatory status: approved.
Key facts
Mechanism of action
Mineralocorticoid receptor agonist
Primary target: Mineralocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is desoxycorticosterone acetate?
desoxycorticosterone acetate (PERCORTEN) is a mineralocorticoid receptor agonist. Route of administration: implantation. Current US regulatory status: approved.
What is the brand name for desoxycorticosterone acetate?
PERCORTEN is a marketed brand name for desoxycorticosterone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of desoxycorticosterone acetate?
desoxycorticosterone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.